Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Med Chem Lett
2014 Mar 03;55:576-81. doi: 10.1021/ml5000228.
Show Gene links
Show Anatomy links
Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.
Deane KJ
,
Summers RL
,
Lehane AM
,
Martin RE
,
Barrow RA
.
???displayArticle.abstract???
The emergence and spread of malaria parasites that are resistant to chloroquine (CQ) has been a disaster for world health. The antihistamine chlorpheniramine (CP) partially resensitizes CQ-resistant (CQR) parasites to CQ but possesses little intrinsic antiplasmodial activity. Mutations in the parasite's CQ resistance transporter (PfCRT) confer resistance to CQ by enabling the protein to transport the drug away from its site of action, and it is thought that resistance-reversers such as CP exert their effect by blocking this CQ transport activity. Here, a series of new structural analogues and homologues of CP have been synthesized. We show that these compounds (along with other in vitro CQ resistance-reversers) inhibit the transport of CQ via a resistance-conferring form of PfCRT expressed in Xenopus laevis oocytes. Furthermore, the level of PfCRT-inhibition was found to correlate well with both the restoration of CQ accumulation and the level of CQ resensitization in CQR parasites.
Björkman,
Field study of cyproheptadine/chloroquine synergism in falciparum malaria.
1990, Pubmed
Björkman,
Field study of cyproheptadine/chloroquine synergism in falciparum malaria.
1990,
Pubmed
Bray,
A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum.
1998,
Pubmed
Burgess,
A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.
2006,
Pubmed
Cooper,
Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum.
2002,
Pubmed
Fidock,
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.
2000,
Pubmed
Harrowven,
Intramolecular radical additions to pyridines.
2003,
Pubmed
Högberg,
Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake.
1981,
Pubmed
Kelly,
Discovery of dual function acridones as a new antimalarial chemotype.
2009,
Pubmed
Kyle,
Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys.
1993,
Pubmed
Lee,
Copper-catalyzed asymmetric reduction of 3,3-diarylacrylonitriles.
2007,
Pubmed
Lehane,
Efflux of a range of antimalarial drugs and 'chloroquine resistance reversers' from the digestive vacuole in malaria parasites with mutant PfCRT.
2010,
Pubmed
Martin,
Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.
2012,
Pubmed
,
Xenbase
Martin,
Chloroquine transport via the malaria parasite's chloroquine resistance transporter.
2009,
Pubmed
,
Xenbase
Murray,
Global malaria mortality between 1980 and 2010: a systematic analysis.
2012,
Pubmed
Nakornchai,
Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
2006,
Pubmed
Ogungbamigbe,
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
2008,
Pubmed
Patel,
Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross.
2010,
Pubmed
Petersen,
Drug-resistant malaria: molecular mechanisms and implications for public health.
2011,
Pubmed
Phyo,
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.
2012,
Pubmed
Sowunmi,
Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children.
1997,
Pubmed
Summers,
Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.
2012,
Pubmed
van Schalkwyk,
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
2006,
Pubmed
Ward,
Is reversal of chloroquine resistance ready for the clinic?
2001,
Pubmed
Warsame,
Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria.
1992,
Pubmed
Yuan,
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
2011,
Pubmed
Zishiri,
A series of structurally simple chloroquine chemosensitizing dibemethin derivatives that inhibit chloroquine transport by PfCRT.
2011,
Pubmed
,
Xenbase
Zishiri,
Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
2011,
Pubmed
,
Xenbase
